Pulmonary embolism (PE) is the leading cause of in-hospital death and the third most
frequent cause of cardiovascular death. The clinical presentation of PE is variable, and …

Pulmonary embolism (PE) continues to represent a significant health care burden and its
incidence is steadily increasing worldwide. Constantly evolving therapeutic options and the …

Abstract Background Pulmonary Embolism Response Teams (PERT) were employed at
multiple institutions to bridge the gap between varied treatment options for acute PE and …

Aims Catheter-directed treatment (CDT) of acute pulmonary embolism (PE) is entering a
growth phase in Europe following a steady increase in the USA in the past decade, but the …

There is a paucity of data regarding the contemporary temporal trends in the adoption of
advanced pulmonary embolism (PE) therapies in the United States as well as the parallel …

Introduction: The risk of venous thromboembolism (VTE) in cancer is currently 12 times
higher than in the general population and even 23 times higher when receiving …

Pulmonary embolism (PE) is the third most common acute cardiovascular disease. The risk
of PE increases with age and mortality is high. Patients are stratified into hemodynamically …

Objectives Up-to-date population-based data on pulmonary embolism (PE)-related sudden
cardiac death (SCD) mortality trends in the United States (US) are scant. We assess the …

Background Over the last few years, the concept of multidisciplinary pulmonary embolism
response teams (PERTs) has emerged to encounter the increasing variety and complexity in …

In this review, the current status of the worldwide experience on different catheter-directed
treatment systems utilized as alternative reperfusion methods in acute pulmonary embolism …